Strategies to prevent rheumatoid arthritis in high-risk patients

Current Opinion in Rheumatology

Volumn 23, Issue 2, 2011, Pages 179-184

  Bykerk, Vivian P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

early inflammatory arthritis; preclinical rheumatoid arthritis; prevention of rheumatoid arthritis; risk factors

Indexed keywords

ABATACEPT; CITRULLINATED PROTEIN ANTIBODY; DEXAMETHASONE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE ACETATE; PLACEBO; PROTEIN ANTIBODY; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG;

ARTHRITIS; ARTICLE; DISEASE COURSE; DRUG EFFICACY; EARLY INTERVENTION; ENVIRONMENTAL FACTOR; EVALUATION; GENETIC RISK; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; IMMUNOMODULATION; MEDICAL LITERATURE; PRIMARY PREVENTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SECONDARY PREVENTION; SMOKING; SYNOVITIS; TREATMENT DURATION; TREATMENT OUTCOME; VACCINATION;

ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; EARLY DIAGNOSIS; HUMANS; RISK FACTORS; SECONDARY PREVENTION;

EID: 79951577858     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOR.0b013e32834379ee     Document Type: Article

References (38)

1. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet 2010; 376:1094-1108.
2. Radner H, Smolen J, Aletaha D. Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid arthritis. Rheumatology (Oxford) 2010. Published on line first 29 October 2010; doi:10.1093/ rheumatology/keq334. pp. 1-8.
3. Mazzantini M, Talarico R, Doveri M, et al. Incident comorbidity among patients with rheumatoid arthritis treated or not with low-dose glucocorticoids: a retrospective study. J Rheumatol 2010; 37:2232-2236.
4. Tang K, Beaton D, Gignac M, et al. The Work Instability Scale for rheumatoid arthritis predicts arthritis-related work transitions within 12 months. Arthritis Care Res (Hoboken) 2010; 62:1578-1587.
5. Feely M, O'Dell J. Update on the use of conventional disease-modifying antirheumatic drugs in the management of rheumatoid arthritis. Curr Opin Rheumatol 2010; 22:316-320.
6. Buch M. Sequential use of biologic therapy in rheumatoid arthritis. Curr Opin Rheumatol 2010; 22:321-329.
7. Van Der Kooij SM, Goekoop-Ruiterman YPM, de Vries-Bouwstra JK, et al. Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis. Ann Rheum Dis 2009; 68:914-921.
8. sBykerk VP, Hazes JM. When does rheumatoid arthritis start and can it be stopped before it does? Ann Rheum Dis 2010; 69:473-475.
9. Kolfenbach J, Deane K, Derber L, et al. A prospective approach to investigating the natural history of preclinical rheumatoid arthritis (RA) using first-degree relatives of probands with RA. Arthritis Rheum 2009; 61:1735-1742.
10. Klareskog L, Catrina A, Paget S. Rheumatoid arthritis. Lancet 2009; 373:659-672.
11. Plenge RM. Recent progress in rheumatoid arthritis genetics: one step towards improved patient care. Curr Opin Rheumatol 2009; 21:262-271.
12. Karlson E, Chibnik L, Kraft P, et al. Cumulative association of 22 genetic variants with seropositive rheumatoid arthritis risk. Ann Rheum Dis 2010; 69:1077-1085.
13. Liao KP, Alfredsson L, Karlson EW. Environmental influences on risk for rheumatoid arthritis. Curr Opin Rheumatol 2009; 21:279-283.
14. Karlson E, Chang S, Cui J, et al. Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis. Ann Rheum Dis 2010; 69:54-60.
15. Pikwer M, Bergstrom U, Nilsson JA, et al. Breast feeding, but not use of oral contraceptives, is associated with a reduced risk of rheumatoid arthritis. Ann Rheum Dis 2009; 68:526-530.
16. Rosell M, Wesley AM, Rydin K, et al. Dietary fish and fish oil and the risk of rheumatoid arthritis. Epidemiology 2009; 20:896-901.
17. Aminian O, Sharifian S, Mehrdad R, etal.Antinuclear antibody and rheumatoid factor in silica-exposed workers. Arh Hig RadaToksikol 2009; 60:185-190.
18. El-Gabalawy HS, Robinson DB, Hart D, et al. Immunogenetic risks of anti cyclical citrullinated peptide antibodies in a North American native population with rheumatoid arthritis and their first-degree relatives. J Rheumatol 2009; 36:1130-1135.
19. Deane KD, Norris JM, Holers VM. Preclinical rheumatoid arthritis: identification, evaluation, and future directions for investigation. Rheum Dis Clin North Am 2010; 36:213-241.
20. Van Dongen H,van Aken J, Lard LR, etal. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2007; 56:1424-1432. (Pubitemid 46764069)
21. Bos W, Dijkmans B, Boers M, etal. Effect of dexamethasone on autoantibody levels and arthritis development in arthralgia patients: a randomized trial. Ann Rheum Dis 2010; 69:571-574.
22. Verstappen S, McCoy M, Roberts C, et al. The beneficial effects of a 3-week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: results of the STIVEA trial. Ann Rheum Dis 2010; 69:503-509.
23. Machold KP, Landewe R, Smolen J, et al. The stop arthritis very early (SAVE) trial, an international multicenter, randomized, double-blind, placebo controlled trial on glucocorticoids in very early arthritis. Ann Rheum Dis 2010; 69:495-502.
24. Emery P, Durez P, Dougados M, et al. The impact of T-cell co-stimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept. Ann Rheum Dis; 2010; 69:510-516.
25. Rantapaä-Dahlqvist S. What happens before the onset of rheumatoid arthritis? Curr Opin Rheumatol 2009; 21:272-278.
26. Nielen MM, van Schaardenburg D, ReesinkHW, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004; 50:380-386. (Pubitemid 38198821)
27. Aletaha D, Neogi T, Silman A, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62:2569-2581.
28. Lundberg K, Wegner N, Yucel-Lindberg T, Venables P. Periodontitis in RA: the citrullinated enolase connection. Nat Rev Rheumatol 2010; 6:727-730.
29. Bos W, Wolbink G, Boers M, et al. Arthritis development in arthralgia patients is strongly associated with anticitrullinated protein antibody status: a prospective cohort study. Ann Rheum Dis 2010; 69:490-494.
30. Mahdi H, Fisher BA, Kallberg H, etal. Specific interaction between genotype, smoking and autoimmunity to citrullinated a-enolase in the etiology of rheumatoid arthritis. Nat Genet 2009; 41:1319-1324.
31. Klareskog L, Widhe M, Hermansson MA, Ronnelid J. Antibodies to citrullinated proteins in arthritis: pathology and promise. Curr Opin Rheumatol 2008; 20:300-305. (Pubitemid 351483320)
32. Westhoff G, Rau R, Zink A. Rheumatoid arthritis patients who smoke have a higher need for DMARDs and feel worse, but they do not have more joint damage than nonsmokers of the same serological grou. Rheumatology (Oxford) 2008; 47:849-854. (Pubitemid 351796371)
33. Mattey D, Brownfield A, Dawes P. Relationship between pack-year history of smoking and response to tumor necrosis factor antagonists in patients with rheumatoid arthritis. J Rheumatol 2009; 36:1180-1187.
34. Klareskog L, Padyukov L, Alfredsson L. Smoking as a trigger for inflammatory rheumatic diseases. Curr Opin Rheumatol 2007; 19:49-54. (Pubitemid 44885727)
35. Arnett F, Edworthy S, Bloch D, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-324. (Pubitemid 18091653)
36. Kraan M, Versendaal H, Jonker M, et al. Asymptomatic synovitis precedes clinically manifest arthritis. Arthritis Rheum 1998; 41:1481-1488. (Pubitemid 28373129)
37. Saleem B, MackieS,Quinn M, etal. Does the use of TNF antagonist therapy in poor prognosis, undifferntiated arthritis prevent progression to rheumatoid arthritis? Ann Rheum Dis 2008; 67:1178-1180.
38. Chodick G, Amital H, Shalem Y, et al. Persistence with statins and onset of rheumatoid arthritis: a population-based cohort study. PLoS Med 2010; 7: 1-13.